Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Terapija Alzheimerove bolesti: sadašnjost i budućnost (CROSBI ID 242531)

Prilog u časopisu | pregledni rad (stručni)

Šipicki, Sara ; Rajić Džolić, Zrinka Terapija Alzheimerove bolesti: sadašnjost i budućnost // Farmaceutski glasnik, 73 (2017), 603-612

Podaci o odgovornosti

Šipicki, Sara ; Rajić Džolić, Zrinka

hrvatski

Terapija Alzheimerove bolesti: sadašnjost i budućnost

Alzheimer’s disease is one of the most prevalent dementia, known since the beginning of the 20th century, women being more aff ected with it. Here we describe the pathophysiology and clinical picture of the disease and give an overview of the current therapeutic options. Th ere are only four drugs, divided in two classes, registered for the therapy of Alzheimer’s disease. Non of the existing drugs are able to stop the progression of the disesase, so we also take a look into the future with hope that the effi cient drug to cure Alzheimer’s disease will soon see the light of the day.

Alzheimerova bolest, patofiziologija, inhibitori acetilkolinesteraze, antagonisti NMDA receptora

nije evidentirano

engleski

Therapy of Alzheimer's disease: present and future

nije evidentirano

Alzheimer's disease, pathophisiology, acethylcholine esterase inhibitor, NMDA receptor antagonist

nije evidentirano

Podaci o izdanju

73

2017.

603-612

objavljeno

0014-8202

Povezanost rada

Farmacija

Indeksiranost